Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionIMC-Chicago, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
IMC-Chicago, LLC ownership in REGN / Regeneron Pharmaceuticals, Inc.

On November 4, 2025 - IMC-Chicago, LLC filed a 13F-HR form disclosing ownership of 0 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on July 22, 2025 disclosing 17,952 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter.

IMC-Chicago, LLC has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 142,600 of underlying shares valued at $110,178,464 USD and put options representing 98,600 of underlying shares valued at $76,182,304 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-04 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -17,952 -100.00 0 -100.00
2025-07-22 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,952 17,952 9,425 0.0042
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F REGENERON PHARMACEUTICALS COM Call 142,600 -37.97 110,178 -37.91 n/a n/a n/a
2026-01-29 2025-12-31 13F REGENERON PHARMACEUTICALS COM Call 229,900 12.64 177,453 54.63 n/a n/a n/a
2025-11-04 2025-09-30 13F REGENERON PHARMACEUTICALS COM Call 204,100 59.08 114,759 70.37 n/a n/a n/a
2025-07-22 2025-06-30 13F REGENERON PHARMACEUTICALS COM Call 128,300 74.08 67,358 44.10 n/a n/a n/a
2025-04-14 2025-03-31 13F REGENERON PHARMACEUTICALS COM Call 73,700 61.98 46,743 44.22 n/a n/a n/a
2025-01-27 2024-12-31 13F REGENERON PHARMACEUTICALS COM Call 45,500 32,411 n/a n/a n/a
2024-07-15 2024-06-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-04-12 2024-03-31 13F REGENERON PHARMACEUTICALS COM Call 16,500 43.48 15,881 57.24 n/a n/a n/a
2024-02-09 2023-12-31 13F REGENERON PHARMACEUTICALS COM Call 11,500 -56.60 10,100 -53.69 n/a n/a n/a
2023-10-12 2023-09-30 13F REGENERON PHARMACEUTICALS COM Call 26,500 -55.39 21,808 -48.90 n/a n/a n/a
2023-07-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM Call 59,400 138.55 42,681 108.62 n/a n/a n/a
2023-04-24 2023-03-31 13F REGENERON PHARMACEUTICALS COM Call 24,900 48.21 20,460 68.79 n/a n/a n/a
2023-04-24 2022-12-31 13F/A REGENERON PHARMACEUTICALS COM Call 16,800 -20.38 12,121 -16.61 n/a n/a n/a
2023-02-09 2022-12-31 13F REGENERON PHARMACEUTICALS COM Call 16,800 12 n/a n/a n/a
2022-11-08 2022-09-30 13F REGENERON PHARMACEUTICALS COM Call 21,100 14,535 n/a n/a n/a
2022-04-19 2022-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-08 2021-12-31 13F REGENERON PHARMACEUTICALS COM Call 18,800 -50.91 11,873 -48.77 n/a n/a n/a
2021-11-05 2021-09-30 13F REGENERON PHARMACEUTICALS COM Call 38,300 81.52 23,178 96.67 n/a n/a n/a
2021-08-06 2021-06-30 13F REGENERON PHARMACEUTICALS COM Call 21,100 -39.37 11,785 -28.42 n/a n/a n/a
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM Call 34,800 -69.37 16,465 -70.00 n/a n/a n/a
2021-02-17 2020-12-31 13F REGENERON PHARMACEUTICALS COM Call 113,600 218.21 54,881 174.62 n/a n/a n/a
2020-11-17 2020-09-30 13F REGENERON PHARMACEUTICALS COM Call 35,700 21.02 19,984 8.62 n/a n/a n/a
2020-08-14 2020-06-30 13F REGENERON PHARMACEUTICALS COM Call 29,500 -41.12 18,398 -24.79 n/a n/a n/a
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM Call 50,100 43.97 24,463 87.21 n/a n/a n/a
2020-02-13 2019-12-31 13F REGENERON PHARMACEUTICALS COM Call 34,800 120.25 13,067 198.13 n/a n/a n/a
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS COM Call 15,800 -51.53 4,383 -57.05 n/a n/a n/a
2019-08-15 2019-06-30 13F REGENERON PHARMACEUTICALS COM Call 32,600 103.75 10,204 55.31 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Call 16,000 -23.44 6,570 -15.83 n/a n/a n/a
2019-04-24 2018-12-31 13F REGENERON PHARMACEUTICALS COM Call 20,900 7,806 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F REGENERON PHARMACEUTICALS COM Put 98,600 -18.44 76,182 -18.36 n/a n/a n/a
2026-01-29 2025-12-31 13F REGENERON PHARMACEUTICALS COM Put 120,900 0.75 93,319 38.31 n/a n/a n/a
2025-11-04 2025-09-30 13F REGENERON PHARMACEUTICALS COM Put 120,000 7.43 67,472 15.06 n/a n/a n/a
2025-07-22 2025-06-30 13F REGENERON PHARMACEUTICALS COM Put 111,700 59.12 58,642 31.71 n/a n/a n/a
2025-04-14 2025-03-31 13F REGENERON PHARMACEUTICALS COM Put 70,200 68.35 44,523 49.89 n/a n/a n/a
2025-01-27 2024-12-31 13F REGENERON PHARMACEUTICALS COM Put 41,700 317.00 29,704 182.57 n/a n/a n/a
2024-10-25 2024-09-30 13F REGENERON PHARMACEUTICALS COM Put 10,000 -13.04 10,512 -13.02 n/a n/a n/a
2024-07-15 2024-06-30 13F REGENERON PHARMACEUTICALS COM Put 11,500 -18.44 12,087 -10.94 n/a n/a n/a
2024-04-12 2024-03-31 13F REGENERON PHARMACEUTICALS COM Put 14,100 -42.21 13,571 -36.67 n/a n/a n/a
2024-02-09 2023-12-31 13F REGENERON PHARMACEUTICALS COM Put 24,400 47.88 21,430 57.83 n/a n/a n/a
2023-10-12 2023-09-30 13F REGENERON PHARMACEUTICALS COM Put 16,500 -66.80 13,579 -61.98 n/a n/a n/a
2023-07-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM Put 49,700 32.18 35,711 15.59 n/a n/a n/a
2023-04-24 2023-03-31 13F REGENERON PHARMACEUTICALS COM Put 37,600 69.37 30,895 92.88 n/a n/a n/a
2023-04-24 2022-12-31 13F/A REGENERON PHARMACEUTICALS COM Put 22,200 -15.27 16,017 -11.25 n/a n/a n/a
2023-02-09 2022-12-31 13F REGENERON PHARMACEUTICALS COM Put 22,200 16 n/a n/a n/a
2022-11-08 2022-09-30 13F REGENERON PHARMACEUTICALS COM Put 26,200 18,048 n/a n/a n/a
2022-04-19 2022-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-08 2021-12-31 13F REGENERON PHARMACEUTICALS COM Put 23,700 -43.17 14,967 -40.69 n/a n/a n/a
2021-11-05 2021-09-30 13F REGENERON PHARMACEUTICALS COM Put 41,700 64.17 25,236 77.88 n/a n/a n/a
2021-08-06 2021-06-30 13F REGENERON PHARMACEUTICALS COM Put 25,400 -43.43 14,187 -33.22 n/a n/a n/a
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM Put 44,900 -38.58 21,244 -39.84 n/a n/a n/a
2021-02-17 2020-12-31 13F REGENERON PHARMACEUTICALS COM Put 73,100 108.26 35,315 79.74 n/a n/a n/a
2020-11-17 2020-09-30 13F REGENERON PHARMACEUTICALS COM Put 35,100 -10.91 19,648 -20.04 n/a n/a n/a
2020-08-14 2020-06-30 13F REGENERON PHARMACEUTICALS COM Put 39,400 -23.20 24,572 -1.90 n/a n/a n/a
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM Put 51,300 -0.97 25,049 28.79 n/a n/a n/a
2020-02-13 2019-12-31 13F REGENERON PHARMACEUTICALS COM Put 51,800 295.42 19,450 435.22 n/a n/a n/a
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS COM Put 13,100 -50.19 3,634 -55.86 n/a n/a n/a
2019-08-15 2019-06-30 13F REGENERON PHARMACEUTICALS COM Put 26,300 38.42 8,232 5.51 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Put 19,000 -21.49 7,802 -13.69 n/a n/a n/a
2019-04-24 2018-12-31 13F REGENERON PHARMACEUTICALS COM Put 24,200 9,039 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.